1. Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood;LM Morton,2006
2. Treatment decisions for elderly patients with haematological malignancies: a dilemma. Lancet Oncol;F Peyrade,2012
3. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d’Etudes des Lymphomes de l’Adulte. Blood;B Coiffier,2010
4. Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial. Lancet Oncol;F Peyrade,2011
5. The proportion of activated B-cell like subtype among de novo diffuse large B-cell lymphoma increases with age. Haematologica;S Mareschal,2011